PREGVIT-PLUS
Natural health product licensed in Canada
- Licence holder
- Pharmaline Inc.
- NPN or DIN-HM
- 80071058
- Status
- Inactive licence
- Licence date
- 13 July 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 30 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Oxyde de zinc | 7 milligramme | 7,000 µg |
| Calcium Source : Carbonate de calcium | 24 milligramme | 24,000 µg |
| Cuivre Source : Acétate de cuivre(II) | 1.2 milligramme | 1,200 µg |
| Folate Source : Acide folique | 400 microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 10 microgrammes | Not calculated |
| Huile de poisson Source : Engraulidae - en entier | 260 milligramme | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 8 milligramme | 8,000 µg |
| Niacinamide Source : Niacinamide | 14 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.1 milligramme | 1,100 µg |
| Riboflavine Source : Riboflavine | 1.4 milligramme | 1,400 µg |
| Thiamine Source : Mononitrate de thiamine | 1 milligramme | 1,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 2.2 microgrammes | Not calculated |
| Vitamine C Source : Acide ascorbique | 70 milligramme | 70,000 µg |
| Biotine Source : Biotine | 0.1 milligramme | 100 µg |
| Fer Source : Fumarate de fer (II) | 30 milligramme | 30,000 µg |
| Iode Source : Iodure de potassium | 150 microgrammes | Not calculated |
| Manganèse Source : Chlorure de manganèse (II) | 1 milligramme | 1,000 µg |
| Magnésium Source : Oxyde de magnésium | 50 milligramme | 50,000 µg |
Non-medicinal ingredients
Gélatine, Glycérine, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube effects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps maintain/support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Kidney stone formation has been known to occur. Consult a health care practitioner to determine appropriate supplementation levels. Folate supplementation can mask a vitamin B12 deficiency. If you are unsure wether you are taking enough vitamin B12, consult a health care practitioner prior to use. Hypersensitivity has been known to occur in which case, discontinue use. Zinc supplementation can cause a copper deficiency. If you are unsure whether you are taking enough copper, consult a health care practitioner prior to use. Some people may experience diarrhea. People sensitive to nicotinic acid may experience flushing of the skin that is mild and transient.
Source
Official Health Canada record, licence 80071058
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.